Core Viewpoint - The Hong Kong Stock Connect innovative drug sector is experiencing a rebound, with significant trading activity and price increases among leading innovative drug companies, indicating a shift in the market dynamics for innovative pharmaceuticals in China [1][3]. Group 1: Market Performance - On December 23, the Hong Kong Stock Connect innovative drug ETF (520880) reached a peak increase of 1.53% and recorded over 1.4 billion yuan in trading volume [1]. - Leading companies in the innovative drug sector, such as CSPC Pharmaceutical Group, saw stock price increases exceeding 5%, while others like 3SBio and Hengrui Medicine rose over 2% [1]. Group 2: Investment Insights - Analysts from Zhongtai Securities noted that the current innovative drug market differs from the 2019-2021 period, as it has transitioned from narrative to actual performance, with trading volumes hitting new highs, reflecting a leap in China's innovative capabilities [1]. - Changjiang Securities emphasized that the innovative drug sector is entering a new cycle of policy support, suggesting a focus on high-quality innovative drug assets with strong overseas potential [3]. Group 3: ETF Characteristics - The Hong Kong Stock Connect innovative drug ETF (520880) tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index, which has three unique advantages: it exclusively includes innovative drug companies, has a high concentration of leading firms (over 72% in the top ten), and employs measures to control risks associated with less liquid stocks [3][4]. - The ETF's current market price is close to its initial listing price, presenting a potential value opportunity for investors [3]. Group 4: Composition and Strategy - The top ten holdings of the Hong Kong Stock Connect innovative drug ETF account for 72.57% of the total weight, showcasing significant dominance by leading companies in the sector [4]. - For investors seeking to mitigate volatility while still focusing on innovative drugs, alternative ETFs that include a mix of traditional Chinese medicine and innovative drugs are available, providing a balanced investment approach [4].

科技摩擦背景下，信息安全、产业安全重要性凸显。AI作为核心技术，实现自主可控至关重要。科创 人工智能ETF（589520）及其联接基金（联接A：024560，联接C：024561）重点布局国产AI产业链、 具备较强国产替代特点，前十大重仓股权重占比逾七成，第一大重仓行业半导体占比超一半，集中度 高，具备较强进攻性。同时，该ETF是融资融券标的，是一键布局国产算力的高效工具。 今年以来，中国AI行业继续突飞猛进，特别是春节期间DeepSeek崛起后，众多国产AI大模型步入了"深 度思考"时代。目前，A股AI芯片行业三巨头寒武纪、摩尔线程、沐曦股份的市值加起来已经超过1万亿 元，但距4.4万亿美元（约30万亿元人民币）市值的英伟达，仍有巨大的差距。 业内人士指出在全球AI芯片格局重塑的背景下，中国本土企业正加速突围，寒武纪、摩尔线程与沐曦 股份的竞争态势日趋白热化，随着市场及政策红利的持续释放，这场"三国杀"或将催生中国AI芯片的领 军者。 东海证券建议重点关注国产供应链：①海外对中国大陆的半导体全面管制集中在先进逻辑与存储产业， 上游供应链国产化紧迫性急剧上升；②我国自主可控企业在设备、设备零组件、材料、EDA ...

12月22日早盘， A+H芯片半导体产业链走强，港股方面，商汤-W大涨超7%，中芯国际涨近6%，鸿腾 精密涨近5%，华虹半导体涨超4%。全市场首只聚焦"港股芯片"产业链的港股信息技术ETF（159131） 场内价格现涨1.69%，实时成交额超3000万元。 | | SHE SEE 15 SSE 159 305 605 EL IN FL 1 1 1 1 | | | | F9 品牌盘后 盘加 元阳 阅读 工具 @ (1) > 159131(和田田地水(1) 11.06 (1 0.922 国政 0.015(1.678) 240) 0.90 威空部 37M ICPV 0.9034 ... 图 0.902 +0.015 +1.89% | | | | | | 港股信息技术ETF T | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 090 | | | | | | | | | | | 159131 - | | | | Mark won and the | | | | | | | | 525E CNY 1 ...

| | 分时 8日 1分 5分 15分 ■ | | | | | F9 我前盘后 雷加 九射 图线 工具 @ 0 | > | 化工ETF O | | 516020 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 0.81 | | | | 516020[化工ETF] 13:23 价 0.809 涨跌 0.009(1.13%) 均价 0.808 服交量 5520 | | A .. . | | 0.87 4 | | +0.014 +1.75% | | 0.808 | | | | was and manument | | | | SSE CNY 15:00:13 I/D+ | | 00 / 8 + | | | | | | | | | 0.9496 | 净值击势 | | 华宝化工ETF | | 0.800 | NAW | | | | | | 0.00% | 能 | 55.99% 经济 | -43764 | | 0.793 | | | | | | | 0.9496 | 亞 | 0.818 | 15720 | | | | | | ...

风险提示：以上产品由基金管理人发行与管理，代销机构不承担产品的投资、兑付和风险管理责任。投 资人应当认真阅读《基金合同》、《招募说明书》、《基金产品资料概要》等基金法律文件，了解基金 的风险收益特征，选择与自身风险承受能力相适应的产品。基金过往业绩并不预示其未来表现，基金投 资须谨慎！销售机构（包括基金管理人直销机构和其他销售机构）根据相关法律法规对本基金进行风险 评价，投资者应及时关注基金管理人出具的适当性意见，各销售机构关于适当性的意见不必然一致，且 基金销售机构所出具的基金产品风险等级评价结果不得低于基金管理人作出的风险等级评价结果。基金 合同中关于基金风险收益特征与基金风险等级因考虑因素不同而存在差异。投资者应了解基金的风险收 益情况，结合自身投资目的、期限、投资经验及风险承受能力谨慎选择基金产品并自行承担风险。中国 证监会对上述基金的注册，并不表明其对上述基金的投资价值、市场前景和收益做出实质性判断或保 证。基金投资须谨慎。 MACD金叉信号形成，这些股涨势不错！ 太平洋证券指出，养猪行业产能去化动力持续增强，去化速度或加快。截至10月末，全国能繁母猪存栏 3990万头，较上月末少45万头。行业连续 ...

从估值方面来看，吃喝板块估值处于历史低位，当前或为板块左侧布局较好时机。数据显示，截至昨日 （12月18日）收盘，食品饮料ETF华宝（515710）标的指数细分食品指数市盈率为20.25倍，位于近10 年来6.46%分位点的低位，中长期配置性价比凸显。 展望后市，国信证券指出，当前白酒板块基本面仍在左侧寻底，但估值及持仓双低位、对短期压力反映 较为充分，供需两端的积极信号均有望带来催化。当前板块或进入左侧布局阶段，具备价位、区域话语 权的优质公司有望获取更大增长空间。 深港证券指出，白酒需求端改善或需等待扩内需、鼓励消费政策的落地实施，预计酒企渠道库存、批 价、报表业绩慢于需求改善。当前股价位置下板块行情或先于基本面企稳回升，业绩回落期间渠道库 存、批价等动销或业绩改善的指标有望催化板块行情。龙头企业积极进行股东回报，白酒配置价值凸 显。 吃喝板块今日（12月19日）震荡上行，反映吃喝板块整体走势的食品饮料ETF华宝（515710）开盘后震 荡上行，截至发稿，场内价格涨1.18%。 成份股方面，大众品涨幅居前，部分白酒股亦表现亮眼。截至发稿，安琪酵母大涨超5%，一鸣食品、 新乳业、千禾味业涨超4%，桃李面包、 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 今日（25/12/18）早盘港股科技板块延续调整态势。板块的持续震荡之际，市场资金积极借道相关产品 进行布局。Wind数据显示，12月以来累计超62亿资金加仓恒生科技相关ETF，其中人气产品恒生科技 ETF（513130）共获7.75亿元资金净流入，助推其最新份额增长至596.71亿份，刷新成立（2021/5/24） 以来历史新高。（份额数据来源：交易所，截至2025/12/17） 此外资金面向好态势同样体现在南向资金中。近期流速放缓的南向资金昨日（25/12/17）净流入额达 71.64亿元，展现出逆势加仓的态势，其中净买入集中于港股互联网龙头个股，显示出对板块的配置信 心。近期港股回调或主要受海内外流动性同步收紧的影响，南向资金的大举加仓流入有望为港股互联网 板块的估值修复提供支撑。（数据来源：Wind） 资金流入的背后或是资金对于市场对于科技产业未来发展的信心。东吴证券在研报中指出，从中长期 看，港股AI科技龙头估值处在合理区间，一旦有新的政策或产业催化，资金启动，港股科技板块可能 会有明显反弹。（资料来源：东吴证券-《港股和美股 ...

近期，市场对AI基础设施投资回报和融资可持续性的担忧升温，叠加美联储释放"慢降息"信号，海外科 技板块普遍承压并传导至A股。年末震荡行情窗口，资金或更青睐防御属性较强、股息率优势较明显且 具备底仓配置价值的红利类资产。 （数据来源：Wind，发布于25/12/17） 尽管近期市场波动加剧，红利类主题ETF标杆产品——红利低波ETF（512890）逆势吸金，已连续6个 交易日合计获8亿元资金加仓，四季度以来累计吸金48.75亿元，带动红利低波ETF（512890）最新份额 达218.35亿份，创下成立以来新高，同期基金规模达255.30亿元，成为市场首只且当前仅有的规模突破 250亿元的红利类主题ETF。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ （研报来源：兴业证券-双轮驱动，攻守兼备：掘金岁末年初红利投资机遇-25/12/15） 除了红利低波ETF（512890）近期获得场内资金关注，华泰柏瑞中证红利低波ETF联接Y（022951）也 持续受到个人养老金投资者的青睐。根据2025年基金三季报数据，截至25/9/30，华泰柏瑞中证红利低 波ETF联接Y（022951）基金规模达 ...

Group 1 - The chemical sector experienced significant gains on December 17, with the chemical ETF (516020) rising by 3.48%, reaching a peak increase of 3.74% during the day [1] - Key stocks in the sector included Salt Lake Co. and Tianqi Lithium, both surging over 7%, while other companies like Wanhu Chemical and Xingfa Group saw increases exceeding 5% [1] - Lithium carbonate futures and spot prices surged, with futures rising by 8.5% and spot prices for battery-grade lithium carbonate reaching an average of 97,050 yuan per ton, a daily increase of 1,200 yuan [2] Group 2 - The storage industry in China is expected to see a sustained growth cycle over the next 3 to 5 years, driven by the demand for energy storage solutions in AI data centers [3] - The current valuation of the chemical sector is at a historical low, with the chemical ETF's price-to-book ratio at 2.33, indicating a favorable investment opportunity [3] - The basic chemical sector has attracted significant capital inflow, with a net inflow of over 87 billion yuan in a single day, ranking fourth among 30 major sectors [4] Group 3 - By 2026, the chemical industry is anticipated to enhance its dividend capabilities, presenting high potential dividend yields, as it enters a favorable market phase [5] - The recovery in manufacturing demand and rising raw material prices have led to a continuous inventory replenishment phase for chemical companies, with expectations of a genuine inventory turning point as consumption recovers [5] - The chemical ETF (516020) provides a diversified investment approach, covering various sub-sectors and concentrating on large-cap stocks, thus offering a strategic way to capitalize on the sector's rebound [5]

Market Overview - The A-share market saw a collective rise in major indices, with the Shanghai Composite Index up over 1% and the ChiNext Index up more than 3%, with a trading volume of 1.81 trillion yuan, an increase of 870 billion yuan from the previous day [1][2] - The surge in the market is attributed to three main factors: the strong performance of brokerage stocks, significant movements in broad-based ETFs, and comments from a former Japanese central bank deputy governor easing concerns about global liquidity tightening [1][3] Sector Performance - The optical module sector experienced a strong breakout, with companies like NewEase and Zhongji Xuchuang leading in capital absorption, while the ChiNext AI ETF saw a price increase of 5% and net subscriptions of 162 million units [1][6] - The "anti-involution" theme also performed well, with lithium carbonate futures surging, leading to gains of 3.48% and 3.27% in the chemical and non-ferrous metal ETFs, respectively [1][6] Investment Strategies - Investment institutions are optimistic about a transition from a structural bull market to a more comprehensive bull market by 2026, with a focus on technology and "anti-involution" themes [2][3] - The overall net profit growth for non-financial A-shares is expected to reach 16.5% in 2026, driven by a recovery in profitability across high-growth sectors [3][11] Key Stocks and ETFs - The top-performing ETFs included the ChiNext AI ETF (159363) with a 5% increase, the Double Innovation Leader ETF (588330) with a 4.02% rise, and the Chemical ETF (516020) with a 3.48% gain [2][4] - Notable stocks in the optical module sector included LianTe Technology, which hit a 20% limit up, and NewEase, which rose over 9% to a new closing high [4][6] Future Outlook - The global optical module market is projected to exceed $37 billion by 2029, with significant demand for 800G and 1.6T optical modules expected to peak in 2025 [6][7] - The chemical sector is anticipated to benefit from a recovery in manufacturing demand and rising raw material prices, with a focus on lithium carbonate as a key growth driver in the energy storage industry [11][12]